New England IRB is a central independent review board for sponsors, CROs and individual researchers across North America. Our priority is to ensure the safety of human subjects in clinical trials, and we are committed to an ethical and thorough review process. New England IRB reviews: All Phases of FDA regulated clinical trials: Phase I - IV Phase I/IIa hybrid studies Patient reported outcomes studies Drug, device and biologic studies (including vaccine studies) Registry studies Peri-approval and post-approval studies Socio-behavioral and educational studies Requests for Exemption